The increase in price target from $38 to $46 by UBS analyst Timothy Arcuri suggests a positive outlook on Intel's stock value in the short term, despite maintaining a Neutral rating. This adjustment could lead to increased investor confidence and a potential uptick in stock price as the market adjusts to the new target.